Some studies have reported overactivation of the NLRP3 inflammasomes in patients with CF, leading to excessive production of IL-1β and IL-18 [28, 46–48]; however, these various mechanisms are not the only redundant cellular pathways in mammalian cells. This evidence concerns the gene IL1B and cystic fibrosis.